For example, CXCR4+ cells derived from several RCC cell lines exhibit resistance to therapy (TKIs) and enhanced capability to form spheres in vitro and tumors in vivo compared to CXCR4–cells (14). This evidence concerns the gene CXCR4 and renal cell carcinoma.